Skip to search formSkip to main contentSkip to account menu

Gestrinone

Known as: 13-Ethyl-17-Hydroxy-18,19-Dinor-17Alpha-Pregna-4,9,11-Trien-20-Yn-3-One, Pregna-4,9,11-Trien-20-Yn-3-One, 13-Ethyl-17-Hydroxy-18,19-Dinor-, (17Alpha)-, 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)- 
A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can… 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (2)

Contraceptives, OralProgestins

Narrower (4)

EM5744NemestranR-2323tetrahydrogestrinone
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Doping control analysis in human urine by liquid chromatography-electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: determination of corticosteroids and…
2005
2005
Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes.
Tetrahydrogestrinone (18a-homo-pregna-4,9,11-trien-17beta-ol-3-one, THG) is an anabolic androgenic steroid sold to athletes as an… 
Highly Cited
2005
Highly Cited
2005
Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry.
The discovery of the designer steroid tetrahydrogestrinone (THG) in elite athletes' doping control samples in 2003 demonstrated… 
Review
1999
Review
1999
Today's treatments: medical, surgical and in partnership
  • J. Donnez
  • International journal of gynaecology and…
  • 1999
  • Corpus ID: 20440864
Review
1997
Review
1997
Modern medical management of endometriosis.
Review
1994
Review
1994
A Risk Benefit Assessment of Drugs Used in the Treatment of Endometriosis
SummaryMedical treatments of endometriosis rely upon the hormonal dependence of endometriotic implants for further growth and… 
Review
1993
Review
1993
Changing concepts of medical treatment of endometriosis
Studies on the natural history of endometriosis have demonstrated that the majority of endometriosis implants tend to progress, a… 
1988
1988
Plasma and peritoneal fluid levels of CA 125 in women with endometriosis.
1986
1986
Histologic and ultrastructural changes in human endometriotic implants treated with the antiprogesterone steroid ethylnorgestrienone (gestrinone) during 2 months.
In 20 infertile patients, the laparoscopic, histologic, and ultrastructural characteristics of endometriotic implants were… 
1986
1986
Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol
To understand the mechanism of biological action of gestrinone (R2323), which has a therapeutic effect against endometriosis, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)